Sinofn Health
Sinofn Health
The Regulatory & Clinical Landscape: Kuala Lumpur stands as a pivotal nexus for the ASEAN health supplement and Foods for Special Medical Purposes (FSMP) sector. As the Malaysian Ministry of Health (MOH) and the National Pharmaceutical Regulatory Agency (NPRA) tighten compliance frameworks, manufacturers must align with stringent standards such as MS 1500:2009 (Halal) and international GMP certification.
Procurement Dynamics: Global enterprises are shifting focus towards "Localization with Expertise." SINOFN leverages this by combining Chinese Academy of Sciences (CAS) R&D prowess with local regulatory navigation, ensuring that specialized metabolic formulations meet both clinical efficacy and halal-certified market standards.
Technical Roadmap: Our focus is on "Nutritional Pharmacotherapy"—the integration of bio-active compounds in medical nutrition. We are transitioning from generic supplements to precision-engineered formulas targeting metabolic disorders, such as Phenylketonuria (PKU), providing scalable, affordable, and clinical-grade solutions.
Founded in 2012, backed by CAS research, we are the premier partner for clinical nutrition OEM.
Led by Founder Mrs. GuoHong Liu and a scientific board including Dr. Tan Shengjie (Peking University) and Hans van Dijk (Netherlands), our R&D team ensures that every FSMP product we manufacture is grounded in peer-reviewed clinical logic. From bioactive compound delivery systems to pilot-scale prototyping, we provide a complete industrialization pipeline for global brands.
We provide comprehensive documentation including stability data, certificate of analysis, and manufacturing process validation to support your dossier submission to the NPRA.
Yes, our production lines and supply chain are designed to meet international Halal standards, facilitating smooth market entry into Malaysia and the broader Muslim-majority ASEAN region.
Absolutely. We operate a dedicated pilot-scale prototyping line designed for agile iteration, allowing brands to test formulations before full-scale commercialization.
